H.R. 9702

Medicare-X Choice Act of 2026

2 cosponsors

Where it stands

Introduced Jul 15
Committee Now
House of Representatives —
Senate —
Law —

Introduced Jul 15
Committee Now
House of Representatives —
Senate —
Law —

Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. (Jul 15)

Votes

No roll-call votes yet.

Official summary

No official summary yet.

Text of the bill

Expand all

Sec. 1. Short title

Sec. 2. Establishment and administration of a public health plan

Sec. 3. Exclusion of providers that place additional restrictions on Medicare exchange health plan patients from Federal health care programs

Sec. 4. Reinsurance

Sec. 5. Expansion of tax credit

Sec. 6. Authority to negotiate fair prices for Medicare prescription drugs

Sec. 7. Strengthening antitrust enforcement in health care markets

There are authorized to be appropriated for the purpose of studying health care markets, including anticompetitive practices within those markets, and taking appropriate antitrust enforcement action for each of fiscal years 2027 through 2031, to remain available until expended—

(1) $50,000,000 to the Antitrust Division of the Department of Justice; and

(2) $100,000,000 to the Federal Trade Commission.

Sec. 8. Reports